Citi Starts Millendo Therapeutics Inc. (MLND) at Buy

February 7, 2020 2:37 AM EST Send to a Friend
Citi analyst Joel Beatty initiates coverage on Millendo Therapeutics Inc. (NASDAQ ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login